Trump said he will raise tariffs on $250 billion in Chinese goods to 30% and hike duties on another $300 billion in products to 15%.Politicsread more
Stocks dropped after Donald Trump ordered that U.S. manufacturers find alternatives to their operations in China.US Marketsread more
Federal Reserve Vice Chair Richard Clarida said Friday that the global economy has deteriorated in the past month.Marketsread more
The latest escalation in the trade war ups the odds the economy will fall into recession and that the Fed will aggressively cut rates.Market Insiderread more
Here are the products that stand to be the most affected by China's new tariffs on $75 billion worth of U.S. goods.Marketsread more
"We don't need China and, frankly, would be far better off without them," Trump tweeted.Politicsread more
"My only question is, who is our bigger enemy, Jay Powell or Chairman Xi?" Trump wrote amid a series of tweets that rattled markets Friday.Politicsread more
"I would love this to be clarified. We come to a deal on trade, boy, this market is up 10 to 15%, but without it's going to be worrisome," Jeremy Siegel says.Marketsread more
The final week of August could be highly volatile as markets fret over the economy and the latest developments in trade wars.Market Insiderread more
Tesla solar energy systems reportedly ignited at an Amazon warehouse in Redlands, California last June, and the Seattle e-commerce titan confirmed that it has no further plans...Technologyread more
The death comes as federal and state health officials investigate a slew of lung illnesses in connection to e-cigarette use.Health and Scienceread more
Check out the companies making headlines after the bell:
Blue Apron shares dropped as much as 5 percent during the extended session Tuesday after the meal-kit service announced it would take strategic actions to improve its profitability, including a 4 percent reduction of its workforce.
Tilray shares dropped over 5 percent after hours when the Canadian pharmaceutical and cannabis company reported an adjusted loss of 8 cents. Tilray reported $10.05 million in revenue this quarter, which Tilray CEO Brendan Kennedy says is from medical use. Kennedy said he expects to see Canadian adult use revenue next quarter following Canada's legalization of cannabis in October. Tilray stock has seen massive swings since it became a listed company on the Nasdaq in July.
SurveyMonkey shares rose nearly 6 percent after the company released its first earnings report as a public company. The company reported $65.2 million in revenue, compared with $55.3 million in the year-ago quarter, an 18 percent increase.